Platform
Solutions
Resources
Company
- About Us
- Leadership Team
- Investors
- Press Releases
- Press Kit
- Blog
- Events
- Careers
- Partner With Us
- Contact Us
REQUEST A DEMO

Search

More results...

Generic filters

Platform
- THE SOPHiA DDM™ PLATFORM
  - Genomics
  - Multimodal
- .
Solutions
Resources
Company
- ABOUT SOPHiA GENETICS
- USEFUL LINKS
  - Blog
  - Events
  - Careers
  - Partner With Us
  - Contact Us
REQUEST A DEMO
SIGN IN

Home
5
Documents
5
HCS_IFU_v5.5_CEIVD_CS

HCS_IFU_v5.5_CEIVD_CS

by [email protected] | Jun 27, 2022

File Type: pdf

Categories: Instructions for Use

Tags: Czech

Author: Souvik Ghosh

Search for:

Recent Posts

Partner Spotlight: Dr Alessandra Terracciano
The Andalusian Health Service conduct trio analysis with the SOPHiA DDM™ Platform to identify the underlying cause of 2 neonatal deaths
European Congress of Pathology
BioData World Congress
ASH

Recent Comments

Platform

The SOPHiA DDM™ Platform
Genomics
Multimodal
Alamut™ Visual Plus
OncoPortal™ Plus
SOPHiA GENETICS Integrated Solutions

SOLUTIONS

Oncology
Rare and Inherited Diseases
BioPharma

RESOURCES

Publications
Case Studies
Webinars
Science Hub

Company

About Us
Leadership Team
Investors
Press Releases
Press Kit
Blog

Company

Events
Careers
Partner With Us
Contact Us
Request A Demo

© 2021 SOPHiA GENETICS. All rights reserved. Privacy Policy | Terms of Use | Legal | Sitemap

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).

SOPHiA GENETICS

Platform

The SOPHiA DDM™ Platform
Genomics
Multimodal
Alamut™ Visual Plus
OncoPortal™ Plus
SOPHiA GENETICS Integrated Solutions

SOLUTIONS

Oncology
Rare and Inherited Diseases
BioPharma

RESOURCES

Publications
Case Studies
Webinars
Science Hub

Company

About Us
Leadership Team
Investors
Press Releases
Press Kit
Blog
Events
Careers
Partner With Us
Contact Us
Request A Demo

© 2021 SOPHiA GENETICS. All rights reserved.
Privacy Policy | Terms of Use | Legal | Sitemap

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA Hereditary Cancer Solution, SOPHiA Myeloid Solution, SOPHiA Solid Tumor Solution are available as CE-IVD product for In Vitro Diagnostic Use in Europe, Turkey and Israel. Information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

Somatic gene variant annotations and related content have been powered by, without limitation, The Jackson Laboratory Clinical Knowledgebase (JAX-CKB™).